A large proportion of human breast cancers produce CEA (Heyderman & Neville 1977 , Wahren et al., 1978 , Cove et al., 1979 . Although levels in plasma of patients with breast cancer have only a limited use in diagnosis and monitoring progression of the disease, (Chu & Nemoto 1973 , Coombes et al., 1980 ; National Institutes of Health Consensus Development Conference Statement 1981) measurement of CEA at the tumour level may provide a useful marker of tumour activity in vitro. We therefore measured CEA in media from cultured explants of human breast cancers and detected the marker in 75% of tumours (Miller et al., 1980) . However, these measurements give no indication of the proportion and type of cells producing CEA within the explants. This information may be obtained by histochemical staining techniques and the purpose of this study was to compare the quantitative release of CEA from explants into media during culture with the results from immunoperoxidase staining for CEA.
Histologically-proven breast cancers were obtained from 54 patients at mastectomy. Of these, 4 were classified as infiltrating lobular carcinomas and 50 infiltrating ductal carcinomas (2 mucinous, 1 medullary and 47 showing no special features). Fifty specimens were from the primary tumour and 4 were from invaded lymph node.
Each tumour was cut into explants measuring 4 x 1 x 1 mm. Four weighed explants were placed on lens paper mounted on stainless-steel grids in each of 3 petri-dishes. Waymouths 17B 725/1 medium (2 ml) containing L-glutamine (2 mM), 20 mM Hepes and insulin (10 jg mlP-) was added and the dishes incubated in an atmosphere of 95%02/5%CO2 for 24 h at 37°C. Culture medium was removed and assayed for CEA by radioimmunoassay.
For radioimmunoassay, CEA was prepared from liver secondaries of primary colonic cancer by perchloric acid extraction (Krupey et al., 1968) , followed by chromatography on columns of DEAEcellulose, CM-cellulose, concanavallin A-Sepharose and Sepharose 6B. Rabbit antiserum to the purified CEA was absorbed extensively against perchloric acid extracts of normal human liver, lung, spleen and serum. Using purified CEA both as standard and for labelling (Sturgeon, 1978) , a direct doubleantibody RIA for CEA based on that of Egan et al. (1972) was developed. The assay was standardized using the British Standard for CEA (Laurence et al., 1975) , 1 ng of working standard being equivalent to 0.0058 + 0.0004 units of the British Standard. Standard curves were prepared in culture medium. The working range of the assays for undiluted samples was from 3-70 ug l-l and intra-assay precision averaged over this concentration range was 11.4%. Inter-assay precision was 10.0%, 8.3% and 6.4% at concentrations of 10, 25 and SOpgl-1, respectively.
In order to assess immunohistochemical staining for CEA, 4 explants (4 x I x 1 mm) were cut from each tumour from the area immediately adjacent to that used for tissue culture. The method used was as described previously (Walker 1980 anti-CEA serum (Dako-immunoglobulins A115), which had been absorbed against non-specific crossreacting antigen, was applied followed by the 3-stage peroxidase anti-peroxidase complex method. Controls used were normal rabbit serum in place of the primary antiserum; anti-CEA serum absorbed with CEA: and positive (carcinoma of colon) and negative (normal breast) control tissues.
Staining was assessed as negative (-ve) Figure  1 . The site of staining within cells was either predominantly at the periphery with a faint granular cytoplasmic reaction, or throughout the cytoplasm with occasional focal intensities. All 14 tumours which were graded +ve produced CEA in culture as did 17 of the 20 graded + ve (Table) . However, one half of the tumours which were -ve by the immunoperoxidase method had consistently detectable, but low levels of CEA in media after culture (Figure 2 ). Concentrations of CEA produced during culture were significantly higher (P <0.05) in tumours graded histochemically +ve as compared It is concluded that RIA of media from cultured tumour explants provides a sensitive quantitative estimate of CEA production by breast carcinomas, and that immunohistochemical staining for CEA indicates the proportion and nature of the cells whose activity is being measured within the tumour. It is suggested that, in order to monitor tumour in vitro activity by CEA measurements, both methods should be used in combination.
